SKP2 induces tumorigenesis via Hippo signaling (Zhang et al., 2017) in HCC, and promotes tumor progression in breast cancer via PDCD4 ubiquitination (Li et al., 2019). Here, SKP2 is linked to hepatocellular carcinoma.